Spruce Biosciences, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Spruce Biosciences, Inc. now
Current reporting with the operating signal separated from the noise.
Spruce Biosciences, Inc. nomme Adrian Quartel au poste de Chief Medical Officer, avec effet au 27 juillet 2026
The story matters when it changes Spruce Biosciences, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Spruce Biosciences, Inc.: Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium
The story matters when it changes Spruce Biosciences, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest SPRB filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Spruce Biosciences, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →